Press releases and In the Media.

Check out the latest news articles featuring Scopio

Press Release
April 17, 2024

Scopio Labs Receives Groundbreaking FDA Clearance for First-Ever Digital Bone Marrow Aspirate Application

The company’s 3rd FDA clearance accelerates the shift to AI-powered digital hematopathology, enhancing diagnostic speed and patient care.
Read more
In the Media 5 mins
November 06, 2022

Not under the microscope: Scopio Labs transforms blood testing

Co-founder & CEO Itai Hayut shares how his Israeli startup streamlines the hematologic diagnostic process while rendering blood lab microscopes obsolete.
Link to full article
In the Media 4 mins
October 27, 2022

Creative Destruction: The Rise of Digital Innovations in Clinical Laboratories

Digital innovations are shifting the role of laboratory medicine from “a hidden champion that saves lives” toward a higher visibility representing a new paradigm in standard of care.
Link to full article
In the Media 3 mins
September 26, 2022

Digitizing Blood Tests For Faster Analysis

Scopio Labs built a high-speed scanner that digitizes the process of analyzing blood samples for faster results aided by AI. In the 21st century, says Scopio Labs CEO Itai Hayut, there’s no reason for a lab...
Link to full article
In the Media 4 mins
August 30, 2022

Beckman Coulter and Scopio Labs partnership brings innovative digital solution to the hematology lab

In this video, Beckman Coulter and Scopio Labs announce their exciting new partnership. Listen to Peter Soltani, Senior Vice President at Beckman Coulter, and Itai Hayut, Co-founder and CEO, Scopio Labs...
Link to full article
In the Media 1 min
August 02, 2022

Beckman Coulter and Scopio Labs accelerate adoption of hematology digital cell morphology platform

Beckman Coulter and Scopio Labs have announced a worldwide partnership to accelerate adoption of Scopio’s next generation peripheral blood smear platforms. Using AI, Scopio have developed scanners which...
Link to full article
In the Media 2 mins
June 20, 2022

Replacing microscopes with digitization

Scopio Labs, a medtech company that develops AI-powered diagnostic platforms for earlier and more accurate detection of cancers, infections, and other diseases, has announced that its ground-breaking X100HT...
Link to full article
In the Media 1 min
June 17, 2022

FDA clears Scopio Labs digital cell morphology platform

Scopio Labs received FDA 510(k) clearance for its X100HT hematology digital cell morphology platform with peripheral blood smear review.
Link to full article
In the Media 1 min
June 12, 2022

Scopio Labs Gets FDA Clearance For Blood Smear Device

Israeli digital microscopy company Scopio Labs, announced this week that it has received US FDA 510(k) clearance for its X100HT device with Full-Field Peripheral Blood Smear (PBS) Application to improve the...
Link to full article
In the Media 2 mins
June 10, 2022

High Throughput Hematological Analysis Platform Receives FDA Clearance

Scopio Labs announced that its X100HT device with Peripheral Blood Smear (PBS) Application has received U.S. FDA 510(k) clearance. Coupling high throughput capabilities with the highest resolution for...
Link to full article